American Society of Hematology (ASH) 2022 Annual Meeting

The Latest on COVID-19, Immunity, and Thrombosis Risk

Formula-Fed Extreme Preemies Need More Iron: Study

Beta-thalassemia: Benefits of Gene Therapy Outweigh Costs

ITP: Biologic Beat Placebo, but Few Patients Improved

Steep Price for Surviving Childhood Lymphoma: Epigenetic Aging

MCL: Ibrutinib Could Become the 'New Standard'

Alloantibody Data Exchange Would Save Lives, Reduce Costs

High Response Rates With Talquetamab in Advanced Myeloma

High Price for Gene Therapy ― But Cost-Effective in Sickle Cell

No Need for Strict Neutropenic Diet After HSCT

High-Dose MTX Does Not Reduce CNS Relapse in Pediatric ALL

'Astonishing' Results: Skip Salvage Chemo, Go Straight to HSCT

For Minorities With PE: Less Advanced Treatment, More Mortality

Poorly Matched Stem Cell Transplants Linked to Ancestry

Worldwide Efforts Needed to Close Regional HSCT Utilization Gap

ASH 2022: New Clinical Data Challenge Long-held Assumptions